| Ms Carla Suarez Reyes-cuerva, OT,CHT | |
|
7005 N Maple Ave, Suite 104, Fresno, CA 93720-8009 | |
| (559) 325-3503 | |
| (559) 325-3504 |
| Full Name | Ms Carla Suarez Reyes-cuerva |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 7005 N Maple Ave, Fresno, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043567852 | NPI | - | NPPES |
| OT2716 | Other | CA | CA BD OF OCCUPATIONAL THERAPY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT2716 (California) | Primary |
| 225XH1200X | Occupational Therapist - Hand | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Carla Suarez Reyes-cuerva, OT,CHT 5455 N Marty Ave, Apt. #113, Fresno, CA 93711-6551 Ph: (559) 960-6340 | Ms Carla Suarez Reyes-cuerva, OT,CHT 7005 N Maple Ave, Suite 104, Fresno, CA 93720-8009 Ph: (559) 325-3503 |
News Archive
A new prospective study of patients with Lynch syndrome - an inherited disorder of cancer susceptibility caused by mutations in specific DNA repair genes - provides the first strong evidence that people with Lynch syndrome face significantly increased risks of breast and pancreatic cancers.
Aspen Park Pharmaceuticals, Inc., a private company, today announced that it has acquired worldwide rights from The Ohio State University, through the Ohio State Innovation Foundation, to APP-111. APP-111 is a first-in-class oral, antitubulin targeting agent for the potential treatment for the form of castration resistant prostate cancer that does not respond or becomes resistant to currently available androgen receptor antagonists like XTANDI (enzalutamide) and testosterone reducing agents like ZYTIGA (abiraterone acetate and prednisone).
Naturally elevated levels of the antioxidant urate may slow the progression of Parkinson's disease in men. Researchers from the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) and Harvard School of Public Health (HSPH) examined data from an earlier study and found that, among recently diagnosed Parkinson's patients, those with the highest urate levels had a significantly slower rate of disease progression during the two-year study period.
ZELTIQ Aesthetics, Inc., a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is exhibiting at the 8th European Masters in Aesthetics & Anti-Aging (EMAA) in Paris, October 12-14, 2012, and will highlight CoolCurve+, the newest addition to the applicator platform for the CoolSculpting System.
› Verified 1 days ago
Mrs. Jamie Stanners, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2505 W Shaw Ave, Building A, Fresno, CA 93711 Phone: 559-228-9100 Fax: 559-228-9200 | |
Jennifer Pondoc, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 567 S Kona Ave, Fresno, CA 93727 Phone: 559-430-5790 | |
Megan Parke, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2505 W Shaw Ave, Suite #101, Fresno, CA 93711 Phone: 559-228-9100 | |
Maricela Feria, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5756 N Marks Ave Ste 150, Fresno, CA 93711 Phone: 559-307-3828 Fax: 559-844-5540 | |
Mrs. Julie Ann Evans, OTR, CHT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7108 N Fresno St, Suite 380, Fresno, CA 93720 Phone: 559-903-2386 Fax: 559-451-0564 | |
May Anne Gamueda, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 7300 N Fresno St, Fresno, CA 93720 Phone: 559-448-4500 |